Last update July 16, 2022
Likely Compatibility
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
Levetiracetam in other languages or writings:
Main tradenames from several countries containing Levetiracetam in its composition:
Write us at elactancia.org@gmail.com
e-lactancia is a resource recommended by La Liga de la Leche de México of Mexico
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
Piracetam analog, nootropic and antiepileptic, authorized for use in Europe in infants from 1 month of life. Twice daily oral administration.
It is excreted in human milk in small amounts, much lower than the dose used in newborns and infants (Kohn 2016, Tomson 2007, Johannesson 2005, Greenhill 2004, Kramer 2002), however, higher levels have also been found in human milk that exceed the safe limit of 10% of the relative infant dose, RID.(Dinavitser 2022 & 2021, Kohn 2016)
Infant plasma levels are very low or undetectable. (Kacirova 2021, Paret 2014, Tomson 2007, Johannesson 2005, Kramer 2002).
In a comprehensive review, infant serum levels were 5 to 7 times lower than maternal levels and were below the reference range used for treatment. (Kacirova 2021)
No problems have been observed in infants whose mothers took it (Dinavitser 2019, Lattanzi 2017, Tomson 2007, Johannesson 2005), except for hypotonia in a 7-day-old preterm, somnolence in three fully breastfed infants (Dinavitser 2022) and sedation and vomiting in a 25-day-old infant, whose mothers also took other antiepileptic drugs. (Paret 2014, Kramer 2002)
In one study, 15% of infants had sedation that resolved with partial breastfeeding. All infants gained well in weight. (Dinavitser 2022 & 2021)
Seizures such as neonatal withdrawal syndrome have been described in a non-breastfed newborn whose mother took Levetiracetam and phenobarbital during pregnancy. Symptoms disappeared when breastfeeding began. (Rauchenzauner 2011)
Levetiracetam serum levels decrease by 50% during pregnancy due to accelerated renal elimination. After delivery, concentrations rise to pre-pregnancy levels within a week, so it is advisable to decrease the dose administered to the mother and to monitor the newborn's clinical status. (Reimers 2014, Lopez 2009, Harden 2009, Westin 2008, Tomson 2007)
Various experts consider the use of this medication compatible or very likely compatible during breastfeeding. (Hale 2019, Crettenand 2018, Briggs 2017, Rapcencu 2012, O'Connor 2009, Schaefer 2007, Pennell 2006, Pack 2006, Crawford 2008 and 2005, Greenhill, 2004)
It is recommended to observe for sedation of infants. The transitional shift to partial breastfeeding can solve this problem.(Dinavitser 2022 & 2021)